Dataset: 11.1K articles from the COVID-19 Open Research Dataset (PMC Open Access subset)
All articles are made available under a Creative Commons or similar license. Specific licensing information for individual articles can be found in the PMC source and CORD-19 metadata
.
More datasets: Wikipedia | CORD-19

Logo Beuth University of Applied Sciences Berlin

Made by DATEXIS (Data Science and Text-based Information Systems) at Beuth University of Applied Sciences Berlin

Deep Learning Technology: Sebastian Arnold, Betty van Aken, Paul Grundmann, Felix A. Gers and Alexander Löser. Learning Contextualized Document Representations for Healthcare Answer Retrieval. The Web Conference 2020 (WWW'20)

Funded by The Federal Ministry for Economic Affairs and Energy; Grant: 01MD19013D, Smart-MD Project, Digital Technologies

Imprint / Contact

Results for Query ‹ 2019 novel coronavirus respiratory syndrome medication

2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies – Alternative medication

Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China – 6.2. General Treatment

A precision medicine approach to managing 2019 novel coronavirus pneumonia – Precision treatment for 2019-nCoV pneumonia

COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses – Potential therapeutic strategies against COVID-19

2019-nCoV: The Identify-Isolate-Inform (3I) Tool Applied to a Novel Emerging Coronavirus – Treatment

The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status – Antiviral treatments

Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China – 6.3. Treatment of Severe and Critical Cases

COVID-19: Knowns, Unknowns, and Questions – (vi) Can we find therapeutic options? :::

The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status – Current therapies

COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses – Vaccines for SARS-CoV-2

COVID-19: Knowns, Unknowns, and Questions – (viii) What is the host response to SARS-CoV-2 and pathology of COVID-19? :::

The Novel Coronavirus – A Snapshot of Current Knowledge – Treatment

Coronavirus Disease (COVID-19) and Pediatric Patients: A Review of Epidemiology, Symptomatology, Laboratory and Imaging Results to Guide the Development of a Management Algorithm – Conclusions

National Institute for the Infectious Diseases “L. Spallanzani”, IRCCS. Recommendations for COVID-19 clinical management – Available data on SARS-COV2

A precision medicine approach to managing 2019 novel coronavirus pneumonia – Precision prevention and control for 2019-nCoV pneumonia

National Institute for the Infectious Diseases “L. Spallanzani”, IRCCS. Recommendations for COVID-19 clinical management – Dosage

Emerging novel coronavirus (2019-nCoV)—current scenario, evolutionary perspective based on genome analysis and recent developments – Advances and prospects in developing vaccines and therapeutics

2019-nCoV: The Identify-Isolate-Inform (3I) Tool Applied to a Novel Emerging Coronavirus – Patient Disposition

The different clinical characteristics of corona virus disease cases between children and their families in China – the character of children with COVID-19 – Treatment regimen and prognosis

2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies – Protection

A comprehensive Chinese experience against SARS-CoV-2 in ophthalmology – Before coming to hospital

Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review – Prevention and control

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro – Dear Editor,

A comprehensive Chinese experience against SARS-CoV-2 in ophthalmology – Entering the clinic room

Traditional Chinese herbal medicine for treating novel coronavirus (COVID-19) pneumonia: protocol for a systematic review and meta-analysis – Type of interventions